Keywords:
Outcomes, Outcomes analysis, Ultrasound, Musculoskeletal joint, Interventional non-vascular
Authors:
C. Gianneramo1, F. Bruno1, I. Capretti2, M. V. M. Micelli1, S. Mariani1, F. Arrigoni1, L. Zugaro1, A. Barile1, C. Masciocchi1; 1L'Aquila/IT, 2L' Aquila/IT
DOI:
10.26044/ecr2019/C-1326
Conclusion
We observed a significant improvement of the assessed clinical domains in the majority of the treated patients.
According to our experience,
patients treated with HA infiltration at the hip level find benefit from the treatment both at the first short-term follow-up but also at the long-term follow-up performed on average after 2 ± 1,44 years.
The advancing age and degenerative hip pathology make infiltrative therapies less and less effective; in fact,
patients who underwent infiltrative therapy repeatedly responded less with a reduction of pain-free time-period.
In our experience,
it is advisable to run infiltration cycles at a distance of at least six months to have a greater therapeutic response.
Infiltrative therapy can improve the functionality procrastinating surgical strategies,
increasing the pain-free time-period despite the instrumental progression of the pathology.